BioWorld - Friday, April 3, 2026

BioWorld Science

Aug. 8, 2002

View Archived Issues

Supplementation with oral L-arginine inhibits transdermal nitrate tolerance

Read More

Potential use of allopurinol in endothelial dysfunction associated with chronic heart failure

Read More

Osteoprotegerin deficiency described as a possible cause of juvenile Paget's disease

Read More

Cubist acquires rights to CAB-175

Read More

Inamed acquires rights to botulinum toxin type A

Read More

Thuris and Praecis collaborate on age-related compound development

Read More

Atrix submits IND for new dosage form of Eligard

Read More

Introgen to file European Advexin marketing application in 2004

Read More

AltaRex's OvaRex receives E.U. orphan drug designation for ovarian cancer

Read More

Positive results for ursodiol in colorectal cancer

Read More

Sangart reports positive data for Hemospan

Read More

Avant completes phase II CETi-1 trial enrollment

Read More

New anti-herpes virus drugs in early development at GSK

Read More

FDA advisory committee recommends approval of adefovir dipivoxil for chronic hepatitis B

Read More

AstraZeneca completes Iressa NDA for NSCLC

Read More

Bayer claims new PDE10A inhibitors and their use in cancer

Read More

Servier researchers identify new metalloproteinase inhibitors

Read More

Factor Xa/factor VIIa inhibitors reported by Aventis

Read More

HCV NS3 protease inhibitors prepared and tested at Schering-Plough

Read More